Avient’s specialty-materials transformation is producing record margins and a $73.07 five-year probability-weighted value, despite leverage and legacy environmental liabilities.
Overview
Avient is a global specialty-materials compounder that has moved away from asset-heavy commodity distribution toward customized formulations, advanced composites, colorants, additives, and performance fibers. The company serves packaging, healthcare, defense, consumer, and construction customers through CAI and SEM, with 61% of FY 2025 sales generated outside the United States. Its competitive position rests on proprietary recipes, regulatory certifications, local technical service, 98 plants, and high customer switching costs. **The financial trajectory is improving:** adjusted EBITDA rose from $502.0 million in FY 2023 to $544.5 million in FY 2025, while margin expanded from 16.0% to 16.7% and reached a record 18.3% in Q2 2026. Q2 sales increased 5.8% to $917.0 million, adjusted EPS rose 20.0% to $0.96, and management raised FY 2026 adjusted EPS guidance to $3.10-$3.25, adjusted EBITDA guidance to $575-$603 million, and free cash flow to $210-$230 million. At approximately $43.40, Avient trades at 14.2x normalized P/E, 1.20x sales, and 11.2x trailing EV/EBITDA. **The principal catalyst is continued mix-driven margin expansion and deleveraging**, while the key risks are $1,898.6 million of debt, 2029 maturities, and Calvert City environmental liabilities. The report’s five-year probability-weighted value is $73.07.